← Back to graph
Supplement

N-acetyl cysteine pharmaceutical

Selected indexed studies

  • Lung targeted liposomes for treating ARDS. (J Control Release, 2022) [PMID:35358610]
  • [Acetylcysteine]. (Chudoku Kenkyu, 2008) [PMID:19069128]
  • Preclinical evaluation of N-acetyl-cysteine in association with liposomes of lung surfactant's lipids for the treatment of pulmonary fibrosis and asthma. (Toxicol Appl Pharmacol, 2025) [PMID:40425069]

_Worker-drafted node — pending editorial review._

Connections

N-acetyl cysteine pharmaceutical helps

Sources

Local graph